Literature DB >> 19541580

Validation of the self regulation questionnaire as a measure of health in quality of life research.

Arndt Büssing1, M Girke, C Heckmann, F Schad, T Ostermann, M Kröz.   

Abstract

OBJECTIVES: Several epidemiological studies address psychosomatic self regulation as a measure of quality of life aspects. However, although widely used in studies with a focus on complementary cancer treatment, and recognized to be associated with better survival of cancer patients, it is unclear what the self regulation questionnaire exactly measures. DESIGN AND
SETTING: In a sample of 444 individuals (27% healthy, 33% cancer, 40% other internal diseases), we performed reliability and exploratory factor analyses, and correlated the 16-item instrument with external measures such as the Hospital Anxiety and Depression Scale, the Herdecke Quality of Life questionnaire, and autonomic regulation questionnaire.
RESULTS: The 16-item pool had a very good internal consistency (Cronbach's alpha = 0.948) and satisfying/good (r subsetrt = 0.796) test-retest reliability after 3 months. Exploratory factor analysis indicated 2 sub-constructs: (1) Ability to change behaviour in order to reach goals, and (2) Achieve satisfaction and well-being. Both sub-scales correlated well with quality of life aspects, particularly with Initiative Power/Interest, Social Interactions, Mental Balance, and negatively with anxiety and depression.
CONCLUSIONS: The Self Regulation Questionnaire (SRQ) was found to be a valid and reliable tool which measures unique psychosomatic abilities. Self regulation deals with competence and autonomy and can be regarded as a problem solving capacity in terms of an active adaptation to stressful situations to restore well-being. The tool is an interesting option to be used particularly in complementary medicine research with a focus on behavioural modification.

Entities:  

Mesh:

Year:  2009        PMID: 19541580      PMCID: PMC3351982          DOI: 10.1186/2047-783x-14-5-223

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


Introduction

In the last decade the large application of health-related quality of life (HRQL) questionnaires in medicine brought important new aspects for the treatment of patients with chronic conditions, but disclosed the limitations of generic and disease specific HRQL questionnaires [1]. New studies gave some evidence that questionnaires capturing the individual skills of adaptation, i.e., as sense of coherence or self-regulation, could be more appropriate as prognostic tools in oncology or in different chronic conditions than classical HRQL scales [2,3]. One of these measures is the psychosomatic 'self-regulation' [4-8] which was exclusively used in studies with a focus on complementary cancer treatments. Self-regulation (SR) was reported to represent the "ability actively to achieve well-being, inner equilibrium, appropriate stimulation, a feeling of competence, and a sense of being able to control stressful situations" [4]. However, until now it is unclear what the 16-item SR instrument exactly measures, and thus whether the assessment of SR is in fact a measure of HRQL aspects as suggested by Grossarth-Maticek and Ziegler [4,9], or is a facet of other concepts such as coping, coherence, locus of health control to achieve well-being. To address these questions is of outstanding relevance, because higher SR scores were found to be associated with the unwillingness of cancer patients to participate in double-blind clinical studies [4], but were nevertheless associated with longer survival times when treated with plant extracts from Viscum album L. [5-9] which are widely used in Europe for complementary cancer treatment. In the presented study we intended to investigate reliability, factorial structure and validity of the SR questionnaire in a group of internal medicine patients and healthy controls to draw valid conclusions about the association between survival, self regulation and usage of complementary medicine.

Materials and methods

Participants

In this survey, we analyzed the data of 444 individuals. Patients and healthy control persons were informed of the purpose of the study, assured of confidentiality, gave consent to participate, and completed the questionnaire by themselves. The patients were recruited consecutively in 2000 and 2001 from the Departments of General Internal Medicine, Gastroenterology and Cardiology at the Gemeinschaftskrankenhaus Havelhöhe, the specialist oncology practice at the same hospital, at an oncological practice in Öschelbronn, and an endocrinological practice in Wuppertal. Healthy controls were recruited among the hospital staff, their families and among visitors (convenience sample). Seventy-two % were women, 28% men (mean age 57 ± 14 years). Twenty-seven % were healthy, 21% had breast cancer, 11% colorectal cancers, 13% diabetes mellitus (types 1 and 2), 6% rheumatic diseases, 9% coronary heart diseases, 7% Hashimoto's thyreoiditis, and 5% multiple conditions. 227 participants have been retested 13.1 ± 7.8 weeks later. Among the healthy individuals, 71% were female and 29% male (mean age 54.2 ± 14.3 years). Patients were slightly older than healthy controls. With the exception of coronary heart diseases (33% women, 67% men), and diabetes (48% women, 52% men), women were predominating in the respective disease groups (i.e., breast cancer 100%; Hashimoto's thyreoiditis 100%; rheumatic diseases 79%; colon carcinoma 61%).

Measures

SR was measured with a 16-item pool [4,10], and uses 6-point likert scales ranging from 1 (very weak) to 6 (very strong). Scores 5-6 of the primary tool were assumed to indicate very good SR, scores 4-5 good SR, scores 3.5-4 moderate SR, scores 2-3.5 weak SR, and scores 1-2 very poor SR [4,10]. For the re-validated instrument (SRQ), we decided to use the primary ratings (scores 1-6) and referred them to a 100% level. Thus, scores < 50 will represent lower SR, while scores > 50% indicate higher SR. To test the external validity of the scale and to make statements about the conceptual relationships between SR and quality of life, we enrolled several other instruments:

Quality of life

The HLQ-questionnaire (with five point Likert-scale; Cronbach's alpha = 0.935) differentiates the following factors: Initiative Power & Interest; Social Interactions; Mental Balance; Motility; Physical Complaints; Digestive Well-Being [11]. For this analysis the HLQ scales Initiative Power & Interest (i.e. good ideas, decisive, take initiative, spontaneous reactions, adaption to others and situations, put plans into action, etc.), Social Interactions (i.e., feelings of comfort with others, over-directed, left out, abandoning community life, family life aburden, etc.) and Mental Balance (i.e., nervous/irascibly, well-balanced, happy) were of particular relevance.

Anxiety and depression

The Hospital Anxiety and Depression Scale (HADS) is a highly reliable and valid 14-item instrument which differentiates anxiety and depression. It is a four point Likert-scale with a range from 0 - 21 for both. Higher scoring indicate more symptoms, i.e., ≥ 11 points anxiety or depression are probable, ≥8 - 10 possible cases, < 7 nocases [12,13].

Autonomic functioning

The 12-item 'Autonomic regulation' (aR) scale measures the state of regulation of different autonomic functions in the rhythmic change of rest and activity (and thus is not identically with the cognitive concept of 'self-regulation'). The respective subscales of the long version Orthostatic-Circulatory, Rest/Activity and Digestive Regulation had a satisfying internal consistency (Cronbach-α:rα = 0.65 - 0.75), and satisfying/good test-retest reliability (rrt = 0.70 - 85), and good validity [14,15]. We used a 12-item short form (three point Likert-scale) which includes items which pertain to autonomic functions such as rest/activity rhythms, vertigo, orthostatic regulation, and thermoregulation. Additional questions on activity aim to record self-reported sleep duration and quality, as well as day-time functioning which could reflect the rest/activity rhythm.

Statistical analysis

All data were treated as ordinal data. Cronbach's coefficient alpha [16] was used to evaluate the reliability of our questionnaire and inter-item correlations as published previously [17]. The reliability of the scale was evaluated with internal consistency coefficients. To combine several items with similar content, we relied on the technique of factor analysis (principal component analysis) using Varimax Rotation with Kaiser Normalization. Test-retest reliability has been measured with Spearman Correlation. Reliability and factor analyses, analyses of variance (ANOVA), and correlation analyses were performed with SPSS 15.0 for Windows (SPSS GmbH Software, Munich). We judged p < 0.05 as significant.

Results

Reliability and factor analysis

Reliability analysis of the 16-item pool (Table 1) revealed that the construct had a very good internal consistency (Cronbach's alpha = 0.95). The item difficulty (3.99 [mean value]/6) was 0.66. Exploratory factor analysis (main components; eigenvalues > 1) pointed to a 2-factor solution, which explains 63.2% of variance (Table 1). With respect to side-loadings, item SR8 from scale 2 would fit also to scale 1 (0.517), and item SR 7 from scale 1 also on scale 2 (0.421); side-loadings < 0.4 were not addressed.
Table 1

Mean values and reliability parameters of SRQ questionnaire

Mean values ± SDDifficulty Index (0.66)Factor loadingCorrected Item-Total CorrelationAlpha ifItem deleted(α = 0.948)
1. Ability to Change Behaviour in Order to Reach Goals (α = 0.909; 31.8% of variance)
SR12new behaviour pattern3.93 ± 0.970.66.790.735.944
SR11change behaviour to reach pleasant outcome3.97 ± 0.980.66.763.752.944
SR6threatening situations: behave to emerge safe4.27 ± 1.020.71.726.685.945
SR10find standpoints/behaviour pattern which allow4.03 ± 1.010.67.718.746.944
pleasant problem solving
SR7attain most important objectives4.15 ± 0.980.69.695.752.944
SR9disappointment: no reason for resignation, but cause to change behaviour4.07 ± 1.020.68.674.672.946
SR13because of behaviour desired proximity and required distance to important others4.17 ± 0.990.70.627.669.946
SR4expand various activities until states change to total satisfaction3.66 ± 1.110.61.614.577.948
2. Achieve Satisfaction and Well-Being (α = 0.848; 31.5% of variance)
SR15well-being by daily activities4.02 ± 1.060.67.822.713.945
SR14inner satisfaction over and over again by daily activities4.13 ± 1.050.69.737.757.944
SR2actualize wishes and satisfy needs3.85 ± 1.070.64.735.700.945
SR5arrange different areas of life optimal3.93 ± 1.030.66.726.744.944
SR3situations/states which restore well-being3.87 ± 1.040.65.720.755.944
SR1situations/states which motivate3.97 ± 1.070.66.668.671.946
SR8situations/states which satisfy wishes and needs optimal3.95 ± 1.000.67.651.794.943
SR16behaviour gives rise to situations which cause experiences full of relish3.76 ± 1.030.63.628.658.946

Varimax Rotation with Kaiser Normalization (rotation converged in 3 Iterations);

Kaiser-Mayer-Olkin value = 0.95; Barlett's test for non-sphericity p < 0,001

Mean values and reliability parameters of SRQ questionnaire Varimax Rotation with Kaiser Normalization (rotation converged in 3 Iterations); Kaiser-Mayer-Olkin value = 0.95; Barlett's test for non-sphericity p < 0,001 Factor 1 can be described as "Ability to Change Behaviour in order to reach goals", and factor 2 as "Achieve Satisfaction and Well-Being", which thus has a hedonistic/eudemonistic connotation. The test-retest reliability of the sum-scale was rrt = 0.80, of the factor 1 rrt = 0.76, and of the factor 2 rrt = 0.73.

Self regulation scores in patients and healthy

The Ability to Change Behaviour was significantly higher in men than in women (Table 2), while there were no age-depended differences (data not shown). Patients and healthy individuals differed significantly with respect to their Ability to Change Behaviour and Achieve Satisfaction and Well-Being (Table 2). The highest SR scores were found in healthy controls (which are predominantly of female gender) and patients with coronary heart disease (which are predominantly male), and the lowest in patients with Hashimoto's thyreoiditis and with multi-conditions.
Table 2

Mean values of SRQ scores differentiated with respect to gender, and disease status of tested individuals

Ability to Change Behaviour in order to reach goalsAchieve Satisfaction and Well-Being
all individuals (n = 444)67.3 ± 13.265.9 ± 14.5

Gender
Female (73%)66.1 ± 13.365.2 ± 14.5
Male (27%)70.5 ± 12.467.5 ± 14.3

 F-value10.5912.272
 p-value0.001n.s.

Individuals
Healthy controls71.6 ± 10.571.0 ± 11.0
Breast cancer64.1 ± 13.563.7 ± 14.6
Colorectal cancer67.0 ± 14.265.3 ± 13.6
Diabetes mellitus65.2 ± 16.963.4 ± 20.7
Rheumatic diseases66.4 ± 13.663.8 ± 13.8
Coronary heart diseases70.2 ± 12.767.8 ± 13.7
Hashimoto's thyreoiditis64.6 ± 8.362.3 ± 10.4
multi conditions64.2 ± 12.059.3 ± 13.7

 F-value3.1313.417
 p-value0.0020.001
Mean values of SRQ scores differentiated with respect to gender, and disease status of tested individuals If one analyses the inter-subject effects of the variables gender, age and disease, it became evident that for the scale Ability to Change Behaviour gender was of significant relevance (F = 5.28; p = 0.022), while for the scale Achieve Satisfaction and Well-Being only the disease group was of importance (F = 2.64; p = 0.008).

External validity

The Ability to Achieve Satisfaction and Well-Being was strongly (r > 0.5) and negatively correlated with anxiety and depression, and positively with HRQL, particularly with Initiative Power/Interest. There were several moderate correlations between the SRQ scales and HRQL dimensions and aR (Table 3). In contrast, Physical complaints correlated just weakly with SR. When controlled for age, the magnitude of the respective correlations did not change considerably (data not shown).
Table 3

Correlation analyses between SRQ subscales and other psychological variables

SRQ Factors
Ability to Change Behaviour in order to reach goalsAchieve Satisfaction and Well-Being
SRQ - Ability to Change Behaviour1.00.77
SRQ - Achieve Satisfaction and Well-Being.771.00

HADS - Anxiety-.41-.52
HADS - Depression-.45-.65

HLQ Sum Score.40.55
 Initiative Power/Interest.46.58
  Social interaction.37.48
   Mental balance.33.48
   Motility.26.37
 Digestive well-being.20.33
 Physical complaints.17.28

Autonomic regulation.27.34

* all correlations are significant at the 0.01 level (Spearman's rho; 2-tailed)

Correlation analyses between SRQ subscales and other psychological variables * all correlations are significant at the 0.01 level (Spearman's rho; 2-tailed)

Discussion

The 16-item SRQ had a very good internal consistence and differentiates Ability to Change Behaviour in order to reach goals, and Achieve Satisfaction and Well-Being. The later factor has an obvious hedonistic/eudemonistic connotation, while the first factor can be viewed in the context of problem solving and coping which approaches to the concept of an internal 'locus of control' [18,19] and also Antonovsky's coherence concept (with the three principles of comprehensibility, meaningfulness, manageability) [20]. With respect to external validity, the SRQ sub-scales correlated best with Initiative Power/Interest (and also with Social Interaction and Mental balance), and negatively with anxiety and depression, which underlines the aspect of a creative problem solving capacity. The HLQ scale Initiative Power and Interests heeds topics such as decisiveness, spontaneous reactions, planful actions, adaptation to persons and situations, enhanced personality feeling of security, etc. and thus is in line with the primary concept of the SR. With respect to construct validity, the SRQ deals with competence and autonomy in social concerns, with an active initiative problem solving capacity. SR can be regarded as an active cognitive process in terms of an adaptation to stressful situations (i.e., illness) or displeasing conditions. In contrast to the coping concept of Folkman and Lazarus [21], SR does not focus on the regulation of emotions to avoid stressful situations, but to actively change the unpleasant conditions and to restore well-being. Thus, the SRQ heeds both intrinsic abilities to change behaviour and attitudes, and extrinsic abilities to modify external life concerns. Particularly problem-solving coping strategies were inversely related to psychological distress [22]; and this may be related with higher survival times as observed in cancer patients treated with complementary medicine and higher SR scores [23]. Taken together, the SRQ was found to be a valid and reliable tool which deals with competence and autonomy and can be regarded as a problem solving capacity in terms of an active adaptation to stressful situations to restore well-being. We can not draw any conclusion whether higher SR may impact the courses of disease and thus quality of life - or whether HRQL and autonomic regulation are the 'regulators' of SR. Further studies have to clarify the possible clinical implications of low SR as contrasted with high SR, as indicated by the finding of higher survival times in cancer patients with higher SR scores [23]. Nevertheless, the tool is an interesting option to be used particularly in complementary medicine research with a focus on behavioural modification.
  18 in total

Review 1.  Generalized expectancies for internal versus external control of reinforcement.

Authors:  J B Rotter
Journal:  Psychol Monogr       Date:  1966

2.  The sense of coherence and incidence of cancer--role of follow-up time and age at baseline.

Authors:  Esko Poppius; Hanna Virkkunen; Matti Hakama; Leena Tenkanen
Journal:  J Psychosom Res       Date:  2006-08       Impact factor: 3.006

3.  Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).

Authors:  Ronald Grossarth-Maticek; Renatus Ziegler
Journal:  Forsch Komplementmed       Date:  2006-10-20

4.  Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.

Authors:  R Grossarth-Maticek; Renatus Ziegler
Journal:  Eur J Med Res       Date:  2006-11-30       Impact factor: 2.175

5.  Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.

Authors:  R Grossarth-Maticek; H Kiene; S M Baumgartner; R Ziegler
Journal:  Altern Ther Health Med       Date:  2001 May-Jun       Impact factor: 1.305

6.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

7.  Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).

Authors:  Ronald Grossarth-Maticek; Renatus Ziegler
Journal:  Forsch Komplementmed       Date:  2007-06-22

8.  [Development of a questionnaire for endogenous regulation--a contribution for salutogenesis research].

Authors:  M Kröz; H B von Laue; R Zerm; M Girke
Journal:  Forsch Komplementarmed Klass Naturheilkd       Date:  2003-04

9.  The Herdecke Questionnaire on Quality of Life (HLQ): validation of factorial structure and development of a short form within a naturopathy treated in-patient collective.

Authors:  Thomas Ostermann; Arndt Büssing; Andre-Michael Beer; Peter F Matthiessen
Journal:  Health Qual Life Outcomes       Date:  2005-07-08       Impact factor: 3.186

10.  Validation of a questionnaire measuring the regulation of autonomic function.

Authors:  M Kröz; G Feder; Hb von Laue; R Zerm; M Reif; M Girke; H Matthes; C Gutenbrunner; C Heckmann
Journal:  BMC Complement Altern Med       Date:  2008-06-05       Impact factor: 3.659

View more
  12 in total

1.  Impact of autonomic and self-regulation on cancer-related fatigue and distress in breast cancer patients--a prospective observational study.

Authors:  M Kröz; M Reif; C Bartsch; C Heckmann; R Zerm; F Schad; M Girke
Journal:  J Cancer Surviv       Date:  2013-11-20       Impact factor: 4.442

2.  Validation of the State Version Questionnaire on Autonomic Regulation (State-aR) for cancer patients.

Authors:  M Kröz; F Schad; M Reif; H B von Laue; G Feder; R Zerm; S N Willich; M Girke; B Brinkhaus
Journal:  Eur J Med Res       Date:  2011-10-10       Impact factor: 2.175

3.  Does self-regulation and autonomic regulation have an influence on survival in breast and colon carcinoma patients? results of a prospective outcome study.

Authors:  Matthias Kröz; Marcus Reif; Arndt Büssing; Roland Zerm; Gene Feder; Angelina Bockelbrink; Hans Broder von Laue; Harald Matthes H; Stefan N Willich; Matthias Girke
Journal:  Health Qual Life Outcomes       Date:  2011-09-30       Impact factor: 3.186

4.  Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysis.

Authors:  Arndt Büssing; Christa Raak; Thomas Ostermann
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-14       Impact factor: 2.629

5.  Bendamustine in patients with relapsed or refractory multiple myeloma.

Authors:  M Michael; I Bruns; E Bölke; F Zohren; A Czibere; N N Safaian; F Neumann; R Haas; G Kobbe; Roland Fenk
Journal:  Eur J Med Res       Date:  2010-01-29       Impact factor: 2.175

6.  Effects of eurythmy therapy in the treatment of essential arterial hypertension: a pilot study.

Authors:  Roland Zerm; Ronald Zerm; Froeydis Lutnæs-Mast; Heiner Mast; Matthias Girke; Matthias Kröz
Journal:  Glob Adv Health Med       Date:  2013-01

7.  Impact of a Multimodal and Combination Therapy on Self-Regulation and Internal Coherence in German Breast Cancer Survivors With Chronic Cancer-Related Fatigue: A Mixed-Method Comprehensive Cohort Design Study.

Authors:  Annette Mehl; Marcus Reif; Roland Zerm; Danilo Pranga; Dorothea Friemel; Bettina Berger; Benno Brinkhaus; Christoph Gutenbrunner; Arndt Büssing; Matthias Kröz
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

Review 8.  Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.

Authors:  Gunver S Kienle; Anja Glockmann; Michael Schink; Helmut Kiene
Journal:  J Exp Clin Cancer Res       Date:  2009-06-11

9.  Reliability and validity of a new scale on internal coherence (ICS) of cancer patients.

Authors:  Matthias Kröz; Arndt Büssing; Hans Broder von Laue; Marcus Reif; Gene Feder; Friedemann Schad; Matthias Girke; Harald Matthes
Journal:  Health Qual Life Outcomes       Date:  2009-06-24       Impact factor: 3.186

10.  The Internal Coherence of Breast Cancer Patients Is Associated with the Decision-Making for Chemotherapy and Viscum album L. Treatment.

Authors:  Shiao Li Oei; Anja Thronicke; Matthias Kröz; Cornelia Herbstreit; Friedemann Schad
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.